San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Aethlon Subsidiary to Collaborate With Thomas Jefferson University in Cancer Research

San Diego-based Aethlon Medical Inc., a company developing targeted therapeutic devices to address infectious diseases and cancer, announced that its majority-owned subsidiary Exosome Sciences Inc. has entered into a research collaboration with Thomas Jefferson University.

By Brittany Meiling April 3, 2015 1:04 p.m.   Share
Tease photo

A Stronger Role for Fitness in Health Care Is ACE’s Goal

MEDICINE: Group’s Strengths Could Aid Health Care Mission

It’s not often that the world of 24-hour health clubs and fitness studios intersects with the traditional health care system.

Tease photo

Robotics Fills Key Role in Pharmacy

MEDICINE: System Brings Better Packaging, Tracking

Robots designed and built by a San Marcos manufacturer using a proprietary technology are challenging multibillion-dollar pharmacy automation companies in Asia.

Nominations Open for the 2015 Healthcare Champions Awards

The San Diego Business Journal is now accepting nominations for the 2015 Healthcare Champions Awards, which honors individuals within the San Diego community who have demonstrated exceptional leadership and innovation in the rapidly changing healthcare industry.

HUYA Bioscience Appoints VP for Japan Operations

HUYA Bioscience International announced Wednesday an expansion of its senior management team with the appointment of Yoshiki Shimamura as vice president for Japan operations.

Eolas Therapeutics, AstraZeneca Announce Partnership

Carlsbad-based Eolas Therapeutics Inc. announced Wednesday that is has entered into a worldwide license and partnership agreement with AstraZeneca in a deal potentially worth $145 million.

Sorrento Therapeutics' Stock Gains 37.5 Percent in Q2

Sorrento Therapeutics Inc.’s stock surged almost 20 percent last week, continuing a trend of strong performance, as shares have gained 37.5 percent in the second quarter.

Tease photo

BioMed Developing New UK Facilities for Illumina

San Diego-based BioMed Realty Trust Inc. plans to develop a 155,000-square-foot building in Cambridge, England, that will eventually house the European headquarters of genomic research and development firm Illumina Inc.

La Jolla Pharmaceutical Stock Surges

La Jolla Pharmaceutical Co.’s stock surged by more than 17 percent last week, spurred by director Kevin Tang’s purchase of 53,836 shares last Tuesday.

Palomar Board Votes to Close Hospital

Palomar Health’s Board of Directors voted June 24 to close Palomar Health Downtown Hospital in Escondido.

Backers Put Big Money Behind Spinal Fusion Therapeutic

La Jolla-based Avalon Ventures led a $17 million Series A round for Ankasa Regenerative Therapeutics, handing over $8.5 million of the funding to the upstart biotech working on new tech for reactivating stem cells and tissue regeneration.

Tease photo

Portable PET Scanners to Deliver Diagnostics to Doctors’ Offices

BIOTECH: Current Scanners Cumbersome Costly and Overbooked

Local startup JAS Neuro Imaging has forged a partnership with Maryland-based Brain Biosciences to bring breakthrough brain technology directly to the doctor’s office.

Prebys Donates $100M to Sanford-Burnham

The Sanford-Burnham Medical Research Institute has received a gift of $100 million from prominent San Diego developer and philanthropist Conrad Prebys.

Tease photo

Celladon Suspending R&D Activities

Celladon Corp. announced that it will suspend all research and development activities.

Tease photo

There at the Start(up)

BIOTECH: Hybritech’s Story Is First Chapter of S.D.’s Biotech Biography

The name Hybritech is pinned to local resumes like a badge of honor, as if to say, “I was here in the beginning.”

Richard Slansky Appointed CFO at OncoSec Medical Inc.

OncoSec Medical Inc., a company developing cancer immunotherapies, announced Thursday the appointment of Richard B. Slansky as chief financial officer effective July 6.